Markos Karavitakis Selected Research

Markos Karavitakis Research Topics

6	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 01/2011
5	Neoplasms (Cancer) 01/2022 - 01/2011
2	Margins of Excision 04/2022 - 05/2012
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2011
2	Erectile Dysfunction 04/2020 - 09/2011
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2014 - 01/2011
1	Urolithiasis 09/2022
1	Acute Kidney Injury (Acute Renal Failure) 04/2020
1	Urinary Retention 01/2019
1	Nocturia 11/2017
1	Disease Progression 06/2014
1	Hypertension (High Blood Pressure) 09/2011
1	Carcinogenesis 01/2011
1	Penile Induration (Peyronie's Disease) 12/2010
1	Portal Hypertension 10/2009

1	Phosphodiesterase 5 InhibitorsIBA 04/2020
1	alfuzosin (UroXatral)FDA Link 01/2019
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 11/2017
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2014
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2014
1	A-factor (Streptomyces)IBA 09/2011
1	Antihypertensive Agents (Antihypertensives)IBA 09/2011
1	Prostate-Specific Antigen (Semenogelase)IBA 09/2011
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	Co-Repressor ProteinsIBA 01/2011
1	Estrogens (Estrogen)FDA Link 01/2011
1	Estrogen ReceptorsIBA 01/2011
1	CollagenIBA 12/2010
1	AndrogensIBA 12/2010
1	4-fluoro-N-indan-2-yl-benzamideIBA 10/2009

6	Therapeutics 04/2020 - 01/2011
4	Prostatectomy (Retropubic Prostatectomy) 09/2022 - 05/2012
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 09/2022
1	Operative Time 04/2022
1	Length of Stay 04/2022
1	Catheters 01/2019